[Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers]. [electronic resource]
Producer: 20150615Description: 390-7 p. digitalISSN:- 1769-6917
- Ado-Trastuzumab Emtansine
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase III as Topic
- Drug Approval
- Female
- Humans
- Maytansine -- analogs & derivatives
- Neoplasm Proteins -- metabolism
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2 -- metabolism
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.